SMAD3 and hepatocellular carcinoma: Under the stimulation of heme oxygenase-1 (HO-1), ERK1/2 can phosphorylate SMAD3 at the Thr-179, which may serve as a mechanism for HCC cells to circumvent the growth inhibitory effects of TGF-β144.